The race to make vaccines variant-proof, new AstraZeneca research, and more —Tech in Two

atch up on the most important news today in 2 minutes or less. Get even more news you can use with the Tech in Two newsletter. Sign up here: https://www.wired.com/tt

Learn about your ad choices: dovetail.prx.org/ad-choices